![Robert Ross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Ross
Director/Board Member at
XILIO THERAPEUTICS, INC.
Net worth: - $ as of 2026-08-30
Profile
Robert W.
Ross is currently Chief Executive Officer at Clasp Therapeutics, Inc. since 2023.
Dr. Ross serves as Independent Director at Xilio Therapeutics, Inc. since 2022.
Dr. Ross is Director at Obsidian Therapeutics, Inc. since 2020 and again starting 2026.
Formerly, Dr. Ross was President, Chief Executive Officer & Director at Surface Oncology, Inc. from 2021 to 2023.
Dr. Ross was SVP-Clinical Development & Pharmacovigilance at Genetix Biotherapeutics, Inc. from 2015 to 2016.
Education includes undergraduate studies at Stanford University, graduate degrees from Harvard Medical School, and Columbia University College of Physicians & Surgeons.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-08-30 |
Robert Ross active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Director/Board Member | 2022-06-15 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Director/Board Member | 2020-09-02 |
ManaT Bio, Inc.
 ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Chief Executive Officer | 2023-10-31 |
Former positions of Robert Ross
| Companies | Position | End |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Chief Executive Officer | 2023-08-31 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2016-09-30 |
Training of Robert Ross
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
ManaT Bio, Inc.
ManaT Bio, Inc. Pharmaceuticals: MajorHealth Technology Specializes in discovery, development and delivery of immunotherapies | Health Technology |
- Stock Market
- Insiders
- Robert Ross
